BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ng WT, Chua MLK, Lee AWM. Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis? J Clin Oncol 2022;:JCO2200099. [PMID: 35213233 DOI: 10.1200/JCO.22.00099] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Miao J, Wang L, Tan SH, Li JG, Yi J, Ong EHW, Tan LLY, Zhang Y, Gong X, Chen Q, Xiang YQ, Chen MY, Guo Y, Lv X, Xia WX, Tang L, Deng X, Guo X, Han F, Mai HQ, Chua MLK, Zhao C. Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Clinical Trial. JAMA Oncol 2022;8:1776-85. [PMID: 36227615 DOI: 10.1001/jamaoncol.2022.4656] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]